Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).

Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M, Lacombe K, Cotte L, Bonnard P, Weiss L, Longuet M, Pradier C, Cacoub P; GERMIVIC Study Group.

AIDS Care. 2014 Feb;26(2):176-85. doi: 10.1080/09540121.2013.803014. Epub 2013 Jun 11.

PMID:
23756091
2.

Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education.

Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH.

J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):77-83. doi: 10.1097/QAI.0b013e31818d5a27.

3.

Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.

Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE.

HIV Med. 2010 Apr;11(4):282-8. doi: 10.1111/j.1468-1293.2009.00777.x. Epub 2009 Dec 8.

4.

Suboptimal awareness and comprehension of published preexposure prophylaxis efficacy results among physicians in Massachusetts.

Mimiaga MJ, White JM, Krakower DS, Biello KB, Mayer KH.

AIDS Care. 2014;26(6):684-93. doi: 10.1080/09540121.2013.845289. Epub 2013 Oct 14.

5.

Self-perceived risk of HIV infection and attitudes about preexposure prophylaxis among sexually transmitted disease clinic attendees in South Carolina.

Whiteside YO, Harris T, Scanlon C, Clarkson S, Duffus W.

AIDS Patient Care STDS. 2011 Jun;25(6):365-70. doi: 10.1089/apc.2010.0224. Epub 2011 Apr 6.

PMID:
21470046
6.

Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada.

Leonardi M, Lee E, Tan DH.

Int J STD AIDS. 2011 Dec;22(12):738-41. doi: 10.1258/ijsa.2011.011057.

PMID:
22174057
7.

Perceptions and attitudes about preexposure prophylaxis among seronegative partners and the potential of sexual disinhibition.

Tripathi A, Whiteside YO, Duffus WA.

South Med J. 2013 Oct;106(10):558-64. doi: 10.1097/SMJ.0000000000000010.

PMID:
24096949
8.

Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV Clinic.

Jayakumaran JS, Aaron E, Gracely EJ, Schriver E, Szep Z.

PLoS One. 2016 Feb 10;11(2):e0145670. doi: 10.1371/journal.pone.0145670. eCollection 2016.

9.

Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru.

Tang EC, Sobieszczyk ME, Shu E, Gonzales P, Sanchez J, Lama JR.

AIDS Res Hum Retroviruses. 2014 May;30(5):416-24. doi: 10.1089/AID.2013.0212. Epub 2014 Jan 20.

10.

Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study.

Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW.

AIDS Patient Care STDS. 2012 Feb;26(2):87-94. doi: 10.1089/apc.2011.0283. Epub 2011 Dec 7.

11.

Awareness of and willingness to use oral pre-exposure prophylaxis for HIV prevention among HIV-serodiscordant heterosexual couples: a cross-sectional survey in Xinjiang, China.

Mijiti P, Yahepu D, Zhong X, Sun Y, Zhao T, Zhao Z, Abuduaili Z, Zhou H, Meng F, Dai J, Huang A.

PLoS One. 2013 Jul 16;8(7):e67392. doi: 10.1371/journal.pone.0067392. Print 2013.

12.

Acceptability of an "on-demand" pre-exposure HIV prophylaxis trial among men who have sex with men living in France.

Lorente N, Fugon L, Carrieri MP, Andreo C, Le Gall JM, Cook E, Aboulker JP, Capitant C, Molina JM, Spire B.

AIDS Care. 2012;24(4):468-77. doi: 10.1080/09540121.2011.626394. Epub 2011 Nov 15.

PMID:
22085083
13.

Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand.

Yang D, Chariyalertsak C, Wongthanee A, Kawichai S, Yotruean K, Saokhieo P, Guadamuz T, Suwanvanichkij V, Beyrer C, Chariyalertsak S.

PLoS One. 2013 Oct 8;8(10):e76650. doi: 10.1371/journal.pone.0076650. eCollection 2013.

14.

Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City.

Mehta SA, Silvera R, Bernstein K, Holzman RS, Aberg JA, Daskalakis DC.

Sex Transm Infect. 2011 Jun;87(4):344-8. doi: 10.1136/sti.2010.046284. Epub 2011 Feb 25.

PMID:
21357600
15.

Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru.

Peinado J, Lama JR, Galea JT, Segura P, Casapia M, Ortiz A, Montano SM, Kochel T, Sánchez J.

J Int Assoc Provid AIDS Care. 2013 Jul-Aug;12(4):278-83. doi: 10.1177/1545109712473650. Epub 2013 Feb 19.

PMID:
23422742
16.

Vulnerable infected populations and street markets for ARVs: Potential implications for PrEP rollout in the USA.

Kurtz SP, Buttram ME, Surratt HL.

AIDS Care. 2014 Apr;26(4):411-5. doi: 10.1080/09540121.2013.837139. Epub 2013 Sep 16.

17.

Patterns of sexual behaviour and reported symptoms of STI/RTIs among young people in Croatia--implications for interventions' planning.

Bozicević I, Stulhofer A, Ajduković D, Kufrin K.

Coll Antropol. 2006 Dec;30 Suppl 2:63-70.

PMID:
17508477
18.

Do men who have sex with men use serosorting with casual partners in France? Results of a nationwide survey (ANRS-EN17-Presse Gay 2004).

Velter A, Bouyssou-Michel A, Arnaud A, Semaille C.

Euro Surveill. 2009 Nov 26;14(47). pii: 19416.

19.

Pre-exposure prophylaxis (PrEP) for HIV infection: results of a survey of HIV healthcare providers evaluating their knowledge, attitudes, and prescribing practices.

Tellalian D, Maznavi K, Bredeek UF, Hardy WD.

AIDS Patient Care STDS. 2013 Oct;27(10):553-9. doi: 10.1089/apc.2013.0173. Epub 2013 Sep 20.

PMID:
24053478
20.

Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker LG, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV; iPrEx study team.

Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.

PMID:
25065857
Items per page

Supplemental Content

Write to the Help Desk